Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Vecht

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)P H Hilkens, J Verweij, C J Vecht, et al.
Neurology|July 1, 1995
Neurolymphomatosis of the median nerveM J van den Bent, H G de Bruin, G D Beun, et al.
Neurology|December 1, 1993
Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndromeJ W Moll, H M Markusse, J J Pijnenburg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1990
The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patientsC J Vecht, C J Avezaat, W L van Putten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 22, 1999
Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donorsC de Brabander, J Cornelissen, P A Smitt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphineP L Dellemijn, H B Verbiest, J J van Vliet, et al.
Cancer|July 1, 1992
Types and causes of pain in cancer of the head and neckC J Vecht, A M Hoff, P J Kansen, et al.
Neurology|April 1, 1994
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per dayC J Vecht, A Hovestadt, H B Verbiest, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766F P Hamers, C Pette, B Bravenboer, et al.
Neuroreport|October 6, 1998
Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal hornJ C Holstege, J L Jongen, J H Kennis, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)P H Hilkens, J Verweij, C J Vecht, et al.
Neurology|July 1, 1995
Neurolymphomatosis of the median nerveM J van den Bent, H G de Bruin, G D Beun, et al.
Neurology|December 1, 1993
Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndromeJ W Moll, H M Markusse, J J Pijnenburg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1990
The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patientsC J Vecht, C J Avezaat, W L van Putten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 22, 1999
Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donorsC de Brabander, J Cornelissen, P A Smitt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphineP L Dellemijn, H B Verbiest, J J van Vliet, et al.
Cancer|July 1, 1992
Types and causes of pain in cancer of the head and neckC J Vecht, A M Hoff, P J Kansen, et al.
Neurology|April 1, 1994
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per dayC J Vecht, A Hovestadt, H B Verbiest, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766F P Hamers, C Pette, B Bravenboer, et al.
Neuroreport|October 6, 1998
Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal hornJ C Holstege, J L Jongen, J H Kennis, et al.
Pageof 8